These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2567679)

  • 1. Treatment compliance and self-medication in asthma in France.
    Pretet S; Perdrizet S; Poisson N; Pujet JC; Marsac J
    Eur Respir J; 1989 Apr; 2(4):303-7. PubMed ID: 2567679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
    Boyd G
    Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-acting beta-2 agonists. An attempted response to various questions which can be posed by pneumonologists].
    Vervloet D; Magnan A
    Rev Mal Respir; 1998 Feb; 15(1):25-31. PubMed ID: 9551511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The psychological factors associated with poor compliance with treatment in asthma.
    Bosley CM; Fosbury JA; Cochrane GM
    Eur Respir J; 1995 Jun; 8(6):899-904. PubMed ID: 7589375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of beta-2-mimetic agents in the treatment of asthma].
    Clauzel AM; Rifai N; Vergnaud A; Bony C; Michel FB
    Allerg Immunol (Paris); 1990 Nov; 22(9):377-82. PubMed ID: 1981829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of paradoxical bronchoconstriction with bronchodilator drugs administered by Respimat Soft Mist inhaler: results of phase II single-dose crossover studies.
    Koehler D; Pavia D; Dewberry H; Hodder R
    Respiration; 2004; 71(5):469-76. PubMed ID: 15467324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Asthma and inhalation therapy: the points of view of the patient and the therapist].
    Huchon G
    Allerg Immunol (Paris); 1993 Oct; 25(8):354-8. PubMed ID: 7903537
    [No Abstract]   [Full Text] [Related]  

  • 9. Budesonide + formoterol: new dose regimen. Asthma attacks: a step backwards.
    Prescrire Int; 2008 Apr; 17(94):57. PubMed ID: 18516807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenergic agonists and bronchodilator aerosol therapy in asthma.
    Shim C
    Clin Chest Med; 1984 Dec; 5(4):659-68. PubMed ID: 6151440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchodilator therapy in the management of acute asthma.
    Moan MJ; Fanta CH
    Compr Ther; 1995 Aug; 21(8):421-7. PubMed ID: 8536441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Improvement of compliance in the therapy of asthma--what about evidence and how can the effect be evaluated?].
    Petro W
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S394-7. PubMed ID: 19941244
    [No Abstract]   [Full Text] [Related]  

  • 13. Inappropriate use of inhaled short acting beta-agonists and its association with patient health status.
    Hong SH; Sanders BH; West D
    Curr Med Res Opin; 2006 Jan; 22(1):33-40. PubMed ID: 16393428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The quality of asthma treatment in Denmark. How far are we--and how far are our patients?].
    Ulrik CS; Lange P; Plaschke PP; Backer V; Søes-Petersen U; Harving H
    Ugeskr Laeger; 2008 Jan; 170(4):230-4. PubMed ID: 18282453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmeterol for the treatment of asthma.
    Weinberger M
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):209-11. PubMed ID: 7552921
    [No Abstract]   [Full Text] [Related]  

  • 16. Synergistic effect of combining theophylline and drugs that potentially elevate serum creatine kinase.
    Iwano J; Nakamura Y; Izumida T; Yokota M; Takiguchi Y; Minakuchi K; Sone S
    J Med Invest; 2000 Feb; 47(1-2):9-13. PubMed ID: 10740974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled drugs as risk factors for community-acquired pneumonia.
    Almirall J; Bolíbar I; Serra-Prat M; Palomera E; Roig J; Hospital I; Carandell E; Agustí M; Ayuso P; Estela A; Torres A;
    Eur Respir J; 2010 Nov; 36(5):1080-7. PubMed ID: 20525710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double-blind randomised study.
    Godard P; Greillier P; Pigearias B; Nachbaur G; Desfougeres JL; Attali V
    Respir Med; 2008 Aug; 102(8):1124-31. PubMed ID: 18606533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaler mishandling is very common in patients with chronic airflow obstruction and long-term home nebuliser use.
    Melani AS; Canessa P; Coloretti I; DeAngelis G; DeTullio R; Del Donno M; Giacobbe R; Scarlato I; Serafini A; Barbato N; Vaghi A; Sestini P;
    Respir Med; 2012 May; 106(5):668-76. PubMed ID: 22277996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of compliance in children using inhaled beta adrenergic agonists.
    Zora JA; Lutz CN; Tinkelman DG
    Ann Allergy; 1989 May; 62(5):406-9. PubMed ID: 2566291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.